Suzanne Burdick, Ph.D.'s avatarThe U.S. government’s COVID-19 vaccination effort is a biological weapon project run by the U.S. Department of Defense (DOD), according to Alexandra Latypova, a former pharmaceutical research and development executive with 25 years of industry experience.

Latypova, who oversaw compliance for more than 60 clinical trials, knows the regulatory standards pharmaceutical companies historically were required to meet before bringing a product to market.

“People misunderstand that this is just another instance of Big Pharma corruption,” she told Robert F. Kennedy, Jr., chairman and chief litigation counsel for Children’s Health Defense, during an episode of “RFK Jr. The Defender Podcast.” “It’s much, much bigger than that.”